What is the primary purpose of this filing?

This filing is an amendment to Merck & Co., Inc.'s 10-K annual report for the fiscal year ended December 30, 1995. Amendments are typically filed to correct or update information previously submitted in the original filing.

What kind of information would an investor find in the actual 10-K filing?

A full 10-K filing typically includes detailed financial statements (balance sheets, income statements, cash flow statements), management's discussion and analysis of financial condition and results of operations, information about the company's business, risk factors, legal proceedings, and executive compensation.

Why was this filing made an amendment (10-K/A)?

Amendments to 10-K filings (marked as 10-K/A) are usually made to correct errors, inaccuracies, or omissions in the original filing, or to include information that became material after the original filing date but before the amendment's filing date.

What is the time period covered by this report?

The report covers Merck & Co., Inc.'s fiscal year ending December 30, 1995. The amendment itself was filed on June 13, 1996.

MRK 10-K FY1995 Annual Report — Revenue, Net Income, EPS

Summary

This filing is an amendment to Merck & Co., Inc.'s 1995 10-K annual report, filed on June 13, 1996. While the provided text is a directory listing from the SEC EDGAR database and does not contain the actual financial data or management discussion from the 10-K/A, it indicates that Merck was publicly reporting its financial performance and material events as of December 30, 1995. Investors relying on this filing would have been seeking information on the company's financial health, product pipeline, and strategic outlook in the mid-1990s.

Key Highlights

1The filing is an amendment to Merck & Co., Inc.'s 10-K annual report for the period ending December 30, 1995.
2The original filing date of the 10-K is not specified, but the amendment was filed on June 13, 1996.
3The filing concerns Merck & Co., Inc. (MRK).
4The provided text is a directory listing from the SEC EDGAR database and does not contain the substantive financial details of the report.
5Investors would typically use a 10-K filing to assess a company's past financial performance, its business operations, risks, and future outlook.

Merck & Co., Inc. Annual Report (Amendment), Year Ended Dec 31, 1995

Summary

Key Highlights

Frequently Asked Questions